Correlation Between Leap Therapeutics and Immunic
Can any of the company-specific risk be diversified away by investing in both Leap Therapeutics and Immunic at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Leap Therapeutics and Immunic into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Leap Therapeutics and Immunic, you can compare the effects of market volatilities on Leap Therapeutics and Immunic and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Leap Therapeutics with a short position of Immunic. Check out your portfolio center. Please also check ongoing floating volatility patterns of Leap Therapeutics and Immunic.
Diversification Opportunities for Leap Therapeutics and Immunic
-0.35 | Correlation Coefficient |
Very good diversification
The 3 months correlation between Leap and Immunic is -0.35. Overlapping area represents the amount of risk that can be diversified away by holding Leap Therapeutics and Immunic in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Immunic and Leap Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Leap Therapeutics are associated (or correlated) with Immunic. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Immunic has no effect on the direction of Leap Therapeutics i.e., Leap Therapeutics and Immunic go up and down completely randomly.
Pair Corralation between Leap Therapeutics and Immunic
Given the investment horizon of 90 days Leap Therapeutics is expected to generate 1.16 times more return on investment than Immunic. However, Leap Therapeutics is 1.16 times more volatile than Immunic. It trades about 0.05 of its potential returns per unit of risk. Immunic is currently generating about 0.02 per unit of risk. If you would invest 248.00 in Leap Therapeutics on September 1, 2024 and sell it today you would earn a total of 50.00 from holding Leap Therapeutics or generate 20.16% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Leap Therapeutics vs. Immunic
Performance |
| Timeline |
| Leap Therapeutics |
| Immunic |
Leap Therapeutics and Immunic Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Leap Therapeutics and Immunic
The main advantage of trading using opposite Leap Therapeutics and Immunic positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Leap Therapeutics position performs unexpectedly, Immunic can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Immunic will offset losses from the drop in Immunic's long position.| Leap Therapeutics vs. X4 Pharmaceuticals | Leap Therapeutics vs. Terns Pharmaceuticals | Leap Therapeutics vs. Day One Biopharmaceuticals | Leap Therapeutics vs. PDS Biotechnology Corp |
| Immunic vs. Generation Bio Co | Immunic vs. Kronos Bio | Immunic vs. Erasca Inc | Immunic vs. C4 Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Equity Analysis module to research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities.
Other Complementary Tools
| Content Syndication Quickly integrate customizable finance content to your own investment portal | |
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals |